by CCRM Australia | Aug 1, 2022
This post is by Harmanpreet Harmanpreet, who interned with CCRM Australia. The CCRM Australia Training Program seeks to facilitate training for the future workforce of the Australian regenerative medicine sector and includes an internship program that accepts...
by Stacey Johnson | Jun 10, 2022
The race to produce lab grown food marches on. So where are we in 2022? Two years ago, blogger Elisa D’Arcangelo outlined some of the practical issues associated with developing lab grown meat – namely cost, increasing production and taste. She also explained the...
by Stacey Johnson | May 6, 2022
This month is the 10-year anniversary of when Lisa Willemse and I launched Signals. As you would imagine, blogs come and go so 10 years is a significant milestone. It is also my 10-year anniversary at CCRM and when I was introduced to the regenerative medicine field....
by Stacey Johnson | May 7, 2021
The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with...
by Francesco Zangari | Apr 8, 2021
From the H1N1 pandemic of 2009, Canada recognized it was not ready for a pandemic. “What we were not prepared for was for the pandemic to occur when it did,” said an interviewee at a panel review of Canada’s response to the 2009 H1N1 pandemic. “So, it...
by Michael May | Aug 26, 2020
It is difficult to imagine how many times the opening lines to Charles Dickens’ classic A Tale of Two Cities, written over 160 years ago, has been used to describe the world’s current state of affairs. Yet, I am challenged to identify any other time during my...
Comments